二酶2A通过cGMP依赖的突信号控制淋巴结成熟
Claudia Carlantoni1, Leon M H Liekfeld2, Sandra A Hemkemeyer1
1Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany; German Centre of Cardiovascular Research (DZHK), Partner Site Hamburg/Luebeck/Kiel, Hamburg, Germany.
Developmental cell
|December 30, 2023
概括
二酶2A (PDE2A) 通过控制细胞接触抑制来调节淋巴血管的成熟. 失去PDE2A会影响淋巴发育和膜形成,突出显示它在淋巴内皮细胞中的关键作用.
科学领域:
- 血管生物学 血管生物学
- 分子细胞生物学 分子细胞生物学
- 发展生物学 发展生物学
背景情况:
- 控制淋巴血管发育和功能的机制,特别是细胞接触抑制,仍然在很大程度上是未知的.
- 了解这些过程对于解决淋巴相关疾病至关重要.
研究的目的:
- 在淋巴内皮细胞中识别细胞接触抑制的分子调节剂.
- 阐明二酶2A (PDE2A) 在淋巴血管成熟中的作用.
主要方法:
- 在小鼠胚胎中的条件基因删除 (Pde2a淘汰).
- 使用人类淋巴内皮细胞进行体外研究.
- 对信号通路的分析,包括cGMP,p38和NOTCH.
- 淋巴血管和门发育的组织学检查.
主要成果:
- PDE2A在淋巴细胞内皮细胞中选择性调节接触抑制,但不是血液内皮细胞.
- 在小鼠中,Pde2a的删除会导致淋巴发育不良和异常的门形成.
- 人体淋巴内皮细胞中PDE2A缺乏导致cGMP增加,结节形成受损,细胞循环停止.
- 丢失PDE2A会破坏p38和NOTCH信号交叉,但通过DLL4诱导的NOTCH激活可以部分挽救.
结论:
- 通过控制cGMP水平和下游信号通路,PDE2A是淋巴血管成熟的关键调节者.
- PDE2A微调了cGMP,p38和NOTCH之间的相互作用,这些信号对淋巴内皮细胞功能至关重要.
- 向PDE2A可能为淋巴血管疾病提供治疗潜力.
相关概念视频
Notch Signaling Pathway
4.3K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Amplifying Signals via Second Messengers
7.0K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


